The experience of key technical personnel who will be responsible for the day-to-day operation Maureen Sanderson, Ph.D., will replace Dr. Paul Juarez as MMC Co-leader in the next cycle, given her extensive involvement with the COC and affiliated research projects. She has training in epidemiology and biostatistics (Ph.D., Univ. of Washington, 1996) and is Professor of Obstetrics and Gynecology at MMC. Dr. Sanderson has 14 years experience as Pl for efiologic and intervenfion studies of prostate, breast and cervical cancer that focus on African Americans and Hispanics. She has extensive experience in collaborating with public health departments, community health centers, and other community partners on cancer research. Dr. Sanderson was recruited to MMC in 2008 to serve as the Senior Epidemiologist for the Partnership. She is also the Scienfific Director for the NCI-funded Meharry-CHC CNP (recenfiy renewed for a second cycle), and PI of the full research project (with Dr. Hull as Co-PI). Drs. Sanderson, Hull, and Khabele are currentiy conducfing a pilot study under the Partnership to test a culturally-tailored social markefing intervenfion for increasing HPV vaccine ufilizafion among Hispanic giris. Dr. Sanderson is co-investigator on an efiologic study of breast density funded by the DOD and on the NCI-funded P20, "MMC-VICC: Partners in Cancer Sun/ivorship." Prior to joining MMC, she was Director of the Cancer and Training Cores of an NCMHD EXPORT planning grant at the University of Texas-Houston School of Public Health at Brownsville, which assessed the need for educational messages for women diagnosed with HPV. In 2005 Dr. Sanderson attended the same CBPR training institute as Dr. Hull mentioned above.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Specialized Center--Cooperative Agreements (U54)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1-SRLB-Y)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Meharry Medical College
United States
Zip Code
Brown, Shyretha; Whalen, Margaret (2015) Tributyltin alters secretion of interleukin 1 beta from human immune cells. J Appl Toxicol 35:895-908
Vaiopoulou, Anna; Gazouli, Maria; Papadopoulou, Aggeliki et al. (2015) Serum protein profiling of adults and children with Crohn disease. J Pediatr Gastroenterol Nutr 60:42-7
Sanderson, Maureen; O'Hara, Heather; Foderingham, Nia et al. (2015) Type 2 diabetes and mammographic breast density among underserved women. Cancer Causes Control 26:303-9
Khabele, Dineo; Kabir, Syeda M; Dong, Yuanlin et al. (2014) Preferential effect of akt2-dependent signaling on the cellular viability of ovarian cancer cells in response to EGF. J Cancer 5:670-8
Myers, Jeremy N; Schäffer, Michael W; Korolkova, Olga Y et al. (2014) Implications of the colonic deposition of free hemoglobin-? chain: a previously unknown tissue by-product in inflammatory bowel disease. Inflamm Bowel Dis 20:1530-47
Li, Bo; Lu, Wenfu; Chen, Zhenbang (2014) Regulation of Androgen Receptor by E3 Ubiquitin Ligases: for More or Less. Receptors Clin Investig 1:
Nangami, Gladys; Koumangoye, Rainelli; Shawn Goodwin, J et al. (2014) Fetuin-A associates with histones intracellularly and shuttles them to exosomes to promote focal adhesion assembly resulting in rapid adhesion and spreading in breast carcinoma cells. Exp Cell Res 328:388-400
Patel, Kushal; Kanu, Mohamed; Liu, Jianguo et al. (2014) Factors influencing breast cancer screening in low-income African Americans in Tennessee. J Community Health 39:943-50
Rekhadevi, P V; Diggs, D L; Huderson, A C et al. (2014) Metabolism of the environmental toxicant benzo(a)pyrene by subcellular fractions of human ovary. Hum Exp Toxicol 33:196-202
Li, Bo; Lu, Wenfu; Yang, Qing et al. (2014) Skp2 regulates androgen receptor through ubiquitin-mediated degradation independent of Akt/mTOR pathways in prostate cancer. Prostate 74:421-32

Showing the most recent 10 out of 18 publications